Arrowhead Research Corp (ARWR) Hits New 52-week Low During February 11 Session

Equities Staff |

Arrowhead Research Corp (ARWR) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $3.14, Arrowhead Research Corp dropped to $3.07 for a new 52-week low. By the closing bell, the company's stock was at $3.30 a share for a gain of 2.8%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

Arrowhead Research Corp saw 717,681 shares of its stock trade hands, that's out of 59.55 million shares outstand. The stock has an average daily volume of 1.11 million shares. After hitting a new 52-week low, Arrowhead Research Corp enters the new trading day with a market cap of 196.53 million, a 50-day SMA of $5.01 and a 200-day SMA of $5.89

For a complete fundamental analysis analysis of Arrowhead Research Corp, check out’s Stock Valuation Analysis report for ARWR. To see the latest independent stock recommendations from’s analysts, visit our Research section.

Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.

Arrowhead Research Corp has 104 employees, is led by CEO Christopher Anzalone, and makes its home in Pasedena, CA.

Arrowhead Research Corp is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

IBC Advanced Alloys Corp.

IBC Advanced Alloys Corp is engaged in the production and development of specialty alloy products. Its products include copper alloys and berryllium aluminium alloys.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…